3 completed, 2 unknown. 5 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 3, Unknown 2 |
Follow Radiation Retinopathy: new trials by email Literature Review of Radiation Retinopathy trials Research Report on Radiation Retinopathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole Episcleral Celecoxib - Macula Edema, Radiation Retinopathy | Phase 1 | Unknown | Targeted Therapy Technologies, LLC | 3 | 2021-03-05 | 2023-11-24 |
| Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole Episcleral Dexamethasone - Macular Edema, Radiation Retinopathy | Phase 1 | Unknown | Targeted Therapy Technologies, LLC | 2 | 2019-09-01 | 2023-11-24 |
| Intravitreal Aflibercept Injection for Radiation Retinopathy Aflibercept every 2 months, Aflibercept monthly - Radiation Retinopathy, Macular Edema | Phase 1 | Completed | Washington University School of Medicine | 9 | 2012-11-01 | 2019-04-25 |
| High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy ranibizumab 2.0 mg - Radiation Retinopathy | Phase 1 | Completed | The New York Eye Cancer Center | 10 | 2011-05-01 | 2014-10-02 |
| Effect of Intravitreal Ranibizumab on Radiation Retinopathy Following Plaque Brachytherapy for Choroidal Melanoma Ranibizumab, ranibizumab - Radiation Retinopathy, Choroidal Melanoma | Phase 1 | Completed | The New York Eye Cancer Center | 10 | 2008-10-01 | 2012-04-26 |
Retinal Diseases (3) · Epiretinal Membrane (2) · Macular Edema (2) · Retinal Vein Occlusion (2) · Uveitis, Intermediate (2) · Melanoma (1) · Uveal Melanoma (1)
Eye Diseases (5) · Uveal Diseases (3) · Cardiovascular Diseases (2) · Embolism and Thrombosis (2) · Macular Degeneration (2) · Retinal Degeneration (2) · Retinal Diseases (2) · Thrombosis (2) · Uveitis (2) · Vascular Diseases (2) · Venous Thrombosis (2) · Eye Neoplasms (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1)
Ranibizumab (2) · aflibercept (1)
Targeted Therapy Technologies, LLC (2) · The New York Eye Cancer Center (2) · Washington University School of Medicine (1)
United States (5)
Paul T Finger, MD (2) · Theodore Leng, MD (2) · Prabakar K Rao, MD (1)